Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Frontiers in Medicine|August 15, 2020
COVID-19 and the Kidneys: An UpdateClaudia Benedetti, Meryl Waldman, Gianluigi Zaza, et al.Kidney International Reports|December 13, 2016
Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and RituximabMeryl Waldman, Laurence H Beck, Michelle Braun, et al.Cancer|January 30, 2014
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiationJennifer Tseng, Deborah E Citrin, Meryl Waldman, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Adult minimal-change disease: clinical characteristics, treatment, and outcomesMeryl Waldman, R John Crew, Anthony Valeri, et al.Journal of the American Society of Nephrology : JASN|December 18, 2019
Detection of PLA2R Autoantibodies before the Diagnosis of Membranous NephropathyPeter D Burbelo, Megha Joshi, Adrija Chaturvedi, et al.Kidney International|June 18, 2026
Quantitative Serological Detection of NELL1 Autoantibodies in Membranous NephropathyPeter D Burbelo, Lilian Howard, Tiffany N Caza, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 23, 2013
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritisLaurence Beck, Andrew S Bomback, Michael J Choi, et al.Plos One|March 27, 2019
Autoantibodies are present before the clinical diagnosis of systemic sclerosisPeter D Burbelo, Sarah M Gordon, Meryl Waldman, et al.Clinical Immunology (Orlando, Fla.)|November 26, 2018
Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?Dimitrios C Mastellos, Edimara S Reis, Ali-Reza Biglarnia, et al.Kidney International Reports|July 9, 2025
Risk Factors for Disease Progression for Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)Louis-Philippe Laurin, Margaret Helmuth, Salem Almaani, et al.Pageof 4